Aveanna Healthcare (NASDAQ:AVAH) Stock Price Down 7.4% – Here’s What Happened

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) fell 7.4% during trading on Tuesday . The company traded as low as $8.43 and last traded at $8.2850. 238,229 shares changed hands during trading, a decline of 82% from the average session volume of 1,304,729 shares. The stock had previously closed at $8.95.

Wall Street Analyst Weigh In

AVAH has been the topic of several analyst reports. Raymond James Financial reiterated an “outperform” rating and set a $13.00 price target on shares of Aveanna Healthcare in a report on Friday, December 5th. Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research report on Friday, November 7th. Barclays lifted their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. William Blair began coverage on Aveanna Healthcare in a report on Monday, December 8th. They set an “outperform” rating for the company. Finally, UBS Group increased their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, January 15th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.06.

Aveanna Healthcare Stock Performance

The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The firm has a 50-day moving average of $8.86 and a 200 day moving average of $8.00. The stock has a market capitalization of $1.74 billion, a P/E ratio of 23.14 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.08. The company had revenue of $621.94 million during the quarter, compared to analysts’ expectations of $578.57 million. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. Research analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 12,445 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $97,693.25. Following the sale, the insider directly owned 293,354 shares of the company’s stock, valued at approximately $2,302,828.90. The trade was a 4.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Matthew Buckhalter sold 18,340 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $143,969.00. Following the completion of the sale, the chief financial officer owned 436,980 shares in the company, valued at approximately $3,430,293. This represents a 4.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 259,638 shares of company stock worth $2,109,595 in the last three months. 7.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Assenagon Asset Management S.A. bought a new stake in Aveanna Healthcare during the 3rd quarter worth approximately $7,356,000. Squarepoint Ops LLC grew its holdings in shares of Aveanna Healthcare by 207.0% during the second quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock worth $2,510,000 after purchasing an additional 323,656 shares during the last quarter. Integrated Quantitative Investments LLC acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at $167,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Aveanna Healthcare in the second quarter valued at about $210,000. Finally, Los Angeles Capital Management LLC lifted its position in Aveanna Healthcare by 552.9% during the 2nd quarter. Los Angeles Capital Management LLC now owns 353,934 shares of the company’s stock worth $1,851,000 after buying an additional 299,726 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.